Crispr Therapeutics Ag (CRSP)

Stockholders Equity

$1.75B

Quarterly · Period ending: · USD

CRSP logo

CRSP Stockholders Equity

Latest reported$1.75B
CRSP Quarterly Shareholders Equity (-$29.10M → $1.75B)
High-resolution chart · PNG

CRSP stockholders equity history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Stockholders Equity — Quarterly (USD)
Period endingStockholders Equity (USD)
1,746,551,000
1,814,556,000
1,921,813,000
1,915,982,000
1,711,125,000
1,829,160,000
1,932,080,000
1,939,658,000
1,980,949,000
2,083,936,000
1,882,803,000
1,727,794,000
1,816,028,000
1,854,896,000
1,875,479,000
1,953,954,000
2,090,831,000
2,244,916,000
2,399,460,000
2,512,923,000
2,603,795,000
1,805,498,000
1,664,234,000
1,343,301,000
910,670,000
886,097,000
939,425,000
591,878,000
367,683,000
379,810,000
392,195,000
417,314,000
265,154,000
290,335,000
187,832,000
178,958,000
197,803,000
215,175,000
232,846,000
-62,481,000
135,341,000
89,932,000
-29,097,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.